Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma.

The machine learning-based pathomics signature could act as a novel prognostic marker for patients with ccRCC. Nevertheless, prospective studies with multicentric patient cohorts are still needed for further verifications.